PLCE1 rs2274223: What Your Genotype Means
The rs2274223 variant is a single nucleotide polymorphism located within the PLCE1 gene. It has been studied for its potential association with an increased risk of certain cancers, including gallbladder and gastric cancer.
What each genotype means
Baseline risk profile
This genotype represents the common form of the PLCE1 gene variant. Research suggests that individuals with this genotype do not carry the specific genetic association linked to increased susceptibility for certain gastric or gallbladder cancers observed in other genotypes.
This is the most common genotype in many global populations, though frequencies vary significantly by ancestry.
Slightly increased cancer risk
Carrying one copy of the G allele has been associated in some studies with a statistically higher risk for certain types of cancer, particularly cardia gastric cancer and gallbladder cancer. This association is based on population-level data and does not mean an individual will develop these conditions; please consult with a healthcare provider for personalized screening advice.
This genotype is found at varying frequencies across different ethnic groups, with higher prevalence noted in some East Asian populations.
Increased cancer risk
Individuals with this genotype carry two copies of the G allele, which has been linked in scientific literature to a higher susceptibility for cardia gastric cancer and gallbladder cancer compared to those with the AA genotype. These findings are based on statistical associations in research cohorts and are not a medical diagnosis; discuss your health history and screening needs with a clinician.
This genotype is less common than the AA or AG genotypes in many populations, though it remains a notable variant in specific ancestral groups studied for cancer predisposition.
Understanding the SNP and the PLCE1 Gene
The variant rs2274223 is a specific change in the DNA sequence of the PLCE1 gene, which stands for phospholipase C epsilon 1. This gene provides instructions for making an enzyme that plays a critical role in cell signaling pathways. By cleaving specific membrane phospholipids, the PLCE1 enzyme helps regulate processes such as cell growth, differentiation, and migration. Because these processes are fundamental to how cells function and divide, variations in the gene that encodes this enzyme have been a subject of significant interest in oncology research. While the primary, well-established clinical role of PLCE1 involves rare, recessive mutations that lead to nephrotic syndrome—a type of kidney disorder—the rs2274223 variant is a common polymorphism that is investigated for its more subtle influence on long-term health outcomes, particularly regarding cancer susceptibility in various populations.
Research Associations and Evidence Strength
Research into rs2274223 has primarily focused on its statistical association with cancer risk. Multiple meta-analyses and case-control studies have examined this variant in relation to gastric cancer and gallbladder cancer. For instance, some studies have suggested that the G allele may contribute to an increased susceptibility to certain types of gastric cancer, particularly cardia gastric cancer. Similarly, research has explored its potential role in gallbladder cancer predisposition. However, it is important to note that the evidence for these associations is considered limited and sometimes inconsistent across different ethnic groups and geographic regions. While some studies report statistically significant correlations, others have found weaker or no associations. This variability suggests that the influence of rs2274223 is likely complex, potentially interacting with environmental factors or other genetic markers, and it is not a definitive predictor of disease.
Population Frequency and Variability
The frequency of the rs2274223 variant is known to be variable across different global populations. Genetic studies often highlight that the distribution of the A and G alleles differs significantly between ancestral groups, which may partially explain why some research findings are not consistent when replicated in different cohorts. Because the variant is common, it is found in a large portion of the general population, meaning that carrying the G allele is not an inherently rare or diagnostic event. Researchers often use these frequency differences to conduct subgroup analyses, attempting to determine if the association with cancer risk is specific to certain populations or if it is a universal genetic marker. Due to this variability, findings from one study population cannot always be generalized to others, and current data does not support using this variant as a standalone screening tool for any specific condition.
What This Information Means for You
If you have received information about your rs2274223 genotype, it is essential to understand that this variant is a marker of statistical association rather than a diagnostic test. Having a specific genotype does not mean you will develop a disease, nor does it guarantee protection from one. The associations identified in scientific literature are based on population-level data and do not account for the complex interplay of lifestyle, environment, and the rest of your unique genetic makeup. This information should not be used to make medical decisions or to assess personal health risk in isolation. If you have concerns about your health or family history of cancer, the most appropriate step is to consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your results in the context of your overall health and provide guidance based on established clinical standards.
How common is this variant?
The frequency of the rs2274223 variant is variable across different global populations, with the distribution of the A and G alleles differing significantly between ancestral groups.
Frequently asked questions
Does having the GG genotype mean I will get cancer?
No. The rs2274223 variant is associated with a statistical increase in risk in some studies, but it is not a diagnostic test. Most people with this genotype will never develop the cancers mentioned in these studies.
Is rs2274223 a reliable test for gallbladder cancer?
No. Current evidence is limited and inconsistent, and the variant is not used in clinical practice as a screening or diagnostic tool for gallbladder cancer.
What should I do if I have the G allele?
You should continue to follow standard medical advice for cancer screening and healthy living. If you are concerned about your personal risk, discuss your family history and health concerns with your doctor.
Why do different studies show different results for this SNP?
Genetic associations can vary due to differences in study design, the ancestral background of the participants, and environmental factors. These inconsistencies are common in complex disease research.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2274223?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29